Vir Biotechnology
VIR
VIR
213 hedge funds and large institutions have $827M invested in Vir Biotechnology in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 96 increasing their positions, 51 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
213
Holders Change
-12
Holders Change %
-5.33%
% of All Funds
3.4%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
40
Increased
96
Reduced
51
Closed
51
Calls
$1.94M
Puts
$1.68M
Net Calls
+$265K
Net Calls Change
+$17.8M
Top Buyers
| 1 |
1
BlackRock
New York
|
$148M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$67.2M |
| 3 |
BCM
3
Bridgeway Capital Management
Houston,
Texas
|
$12.6M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$105M |
| 5 |
5
D.E. Shaw & Co
New York
|
$8.25M |
